BR0311209A - Método de produção de unidades de dosagem farmacêuticas para administração oral, uso de etonogestrel, e, tablete - Google Patents

Método de produção de unidades de dosagem farmacêuticas para administração oral, uso de etonogestrel, e, tablete

Info

Publication number
BR0311209A
BR0311209A BR0311209-8A BR0311209A BR0311209A BR 0311209 A BR0311209 A BR 0311209A BR 0311209 A BR0311209 A BR 0311209A BR 0311209 A BR0311209 A BR 0311209A
Authority
BR
Brazil
Prior art keywords
oral administration
pharmaceutical dosage
dosage units
etonogestrel
tablet
Prior art date
Application number
BR0311209-8A
Other languages
English (en)
Inventor
Pieter De Haan
Original Assignee
Akzo Nobel Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nobel Nv filed Critical Akzo Nobel Nv
Publication of BR0311209A publication Critical patent/BR0311209A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/16—Masculine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Diabetes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

"MéTODO DE PRODUçãO DE UNIDADES DE DOSAGEM FARMACêUTICAS PARA ADMINISTRAçãO ORAL, USO DE ETONOGESTREL, E, TABLETE". A presente invenção refere-se a um método de produção de unidades de dosagem farmacêuticas para administração oral compreendendo um composto progestagênico que peroralmente exerce atividade progestagênica equivalente àquela do progestágeno desogestrel.
BR0311209-8A 2002-05-29 2003-05-22 Método de produção de unidades de dosagem farmacêuticas para administração oral, uso de etonogestrel, e, tablete BR0311209A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP02077097 2002-05-29
PCT/EP2003/050189 WO2003099291A1 (en) 2002-05-29 2003-05-22 Progestagenic dosage units

Publications (1)

Publication Number Publication Date
BR0311209A true BR0311209A (pt) 2005-03-15

Family

ID=29558382

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0311209-8A BR0311209A (pt) 2002-05-29 2003-05-22 Método de produção de unidades de dosagem farmacêuticas para administração oral, uso de etonogestrel, e, tablete

Country Status (20)

Country Link
US (1) US20050181040A1 (pt)
EP (1) EP1511495A1 (pt)
JP (1) JP2005529929A (pt)
KR (1) KR20050004869A (pt)
CN (1) CN1655795A (pt)
AR (1) AR040113A1 (pt)
AU (1) AU2003238082A1 (pt)
BR (1) BR0311209A (pt)
CA (1) CA2487279A1 (pt)
HR (1) HRP20041102A2 (pt)
IL (1) IL165085A0 (pt)
IS (1) IS7538A (pt)
MX (1) MXPA04011796A (pt)
NO (1) NO20044900L (pt)
PE (1) PE20040040A1 (pt)
PL (1) PL372760A1 (pt)
RU (1) RU2004138599A (pt)
TW (1) TW200403075A (pt)
WO (1) WO2003099291A1 (pt)
ZA (1) ZA200409110B (pt)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4756153B2 (ja) * 2004-08-27 2011-08-24 富士製薬工業株式会社 低成分含量の錠剤の製造方法
WO2009101182A1 (en) * 2008-02-15 2009-08-20 N.V. Organon Use of etonogestrel for benign prostate hyperplasia (bph).
US10441591B2 (en) 2015-06-30 2019-10-15 Shanghai Jiao Tong University Applications for etonogestrel in preparing anti-prostate cancer products

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2613223B1 (fr) * 1987-04-03 1991-09-13 Biogalenique Laboratoires Forme galenique se presentant sous la forme de grains hydrosolubles, en particulier a base d'un extrait sec de ginkgo biloba, et son procede de preparation
IE71203B1 (en) * 1990-12-13 1997-02-12 Akzo Nv Low estrogen oral contraceptives
IE71202B1 (en) * 1990-12-17 1997-02-12 Akzo Nv Progestagen-only contraceptive
US5395627A (en) * 1992-09-04 1995-03-07 Akzo N.V. Pharmaceutical granulate
IL113816A (en) * 1994-06-08 1998-12-06 Akzo Nobel Nv Pharmaceutical preparations containing desogestral, their preparation and use
US5633011A (en) * 1994-08-04 1997-05-27 Alza Corporation Progesterone replacement therapy
PT782449E (pt) * 1994-09-22 2003-07-31 Akzo Nobel Nv Processo de fabrico de unidades de dosagem por granulacao humida
US5595759A (en) * 1994-11-10 1997-01-21 Alza Corporation Process for providing therapeutic composition
US6395300B1 (en) * 1999-05-27 2002-05-28 Acusphere, Inc. Porous drug matrices and methods of manufacture thereof
KR100342943B1 (ko) * 1999-08-04 2002-07-02 민경윤 비결정질 세푸록심 악세틸 고형분산체, 이의 제조 방법 및 이를 포함하는 경구투여용 조성물

Also Published As

Publication number Publication date
IS7538A (is) 2004-11-18
TW200403075A (en) 2004-03-01
KR20050004869A (ko) 2005-01-12
AR040113A1 (es) 2005-03-16
ZA200409110B (en) 2005-05-18
CA2487279A1 (en) 2003-12-04
IL165085A0 (en) 2005-12-18
JP2005529929A (ja) 2005-10-06
PE20040040A1 (es) 2004-01-31
WO2003099291A1 (en) 2003-12-04
MXPA04011796A (es) 2005-03-31
NO20044900L (no) 2005-02-25
CN1655795A (zh) 2005-08-17
PL372760A1 (en) 2005-08-08
EP1511495A1 (en) 2005-03-09
RU2004138599A (ru) 2005-06-10
US20050181040A1 (en) 2005-08-18
HRP20041102A2 (en) 2004-12-31
AU2003238082A1 (en) 2003-12-12

Similar Documents

Publication Publication Date Title
BR0015188A (pt) Composições farmacêuticas
CY1111470T1 (el) Νεες φαρμακευτικες συνθεσεις που περιεχουν φλιβανσερινη πολυμορφη α
MA32692B1 (fr) Procede de liberation d'une composition pharmaceutique a un patient qui en a besoin
UY30537A1 (es) Formulaciones de flibanserina y metodo para fabricarlas
EA200700049A1 (ru) Препаративные формы оральных лекарственных форм мемантина с модифицированным высвобождением
DK0954314T3 (da) Doseringsformer til bedring af mandlig erektionsdefekt
WO2005065069A3 (en) Pharmaceutical methods, dosing regimes and dosage forms for the treatment of alzheimer's disease
DE69940557D1 (de) Ein hydrokolloid und einen celluloseether enthaltende tablette mit verzögerter freisetzung
WO2008142572A3 (en) Controlled release tablet formulation containing magnesium aluminometasilicate
BR0211198A (pt) Composições farmacêuticas e seu uso
ATE298324T1 (de) Deuterierte 3-piperidinopropiophenone sowie diese verbindungen enthaltende arzneimittel
AP2003002763A0 (en) Controlled release formulations for oral administration
BR0312728A (pt) Formulação em tablete dispersìvel e processo para sua preparação
NO20023551D0 (no) Ibuprofen-inneholdende aktivt middel-preparat
PL377683A1 (pl) System terapeutyczny zawierający amoksycylinę i kwas klawulanowy
BRPI0516545A (pt) uso de óleo de lavanda para a profilaxia e tratamento de neurastenia, distúrbios de somatização e outras doenças associadas ao estresse
BR0311209A (pt) Método de produção de unidades de dosagem farmacêuticas para administração oral, uso de etonogestrel, e, tablete
BRPI0413374A (pt) composições para liberação de base fraca por um perìodo estendido de tempo
TR200301553A1 (tr) İrbesartan etken maddesi içeren yeni oral farmasötik formülasyonlar
EA200701091A1 (ru) Противозачаточный фармацевтический препарат
PL425832A1 (pl) Genisteina oraz jej kompozycja do zastosowania w leczeniu choroby Alzheimera
DK1499278T3 (da) Farmaceutisk doseringsform, som udviser umiddelbar frigivelse, og som omfatter polymorf tibolon
ECSP045461A (es) Unidades de dosificación progestagénica
MY145885A (en) Controlled release formulations for oral administration
ECSP024290A (es) Composiciones farmacéuticas y uso de las mismas

Legal Events

Date Code Title Description
B11A Dismissal acc. art.33 of ipl - examination not requested within 36 months of filing
B11Y Definitive dismissal - extension of time limit for request of examination expired [chapter 11.1.1 patent gazette]